Image

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

Recruiting
18 years of age
Female
Phase N/A

Powered by AI

Overview

The goal of this observational study is to evaluate the quality of life of participants who have undergone implant-based breast surgery. This will be done using the BREAST-Q questionnaire. The study also aims to demonstrate that the fully resorbable TIGR® Matrix is safe and effective.

Description

This national, multicentre, prospective, non-randomized post market surveillance clinical device investigation will be performed to obtain information on the resorbable surgical mesh TIGR® Matrix used during an implant-based breast surgery. Data will be collected on the participants' quality of life as well as on the rate of complications of the device under investigation.

Eligibility

Inclusion Criteria:

  • Women with histologically confirmed breast cancer or precancerosis or genetic preexisting conditions with increased risk of breast cancer or with a family history all with an indication for skin sparing or nipple sparing mastectomy (SSM or NSM); or women with indication of prophylactic operation
  • The health of women must comply with ECOG performance status 0-2
  • The decision for the implementation of the TIGR® Matrix was made before and independently from study enrollment
  • Participant is mentally able to understand the nature, aims, or possible consequences of the clinical investigation
  • Patient information has been handed out and subject signed informed consent
  • Participant has attained full age of 18 years

Exclusion Criteria:

  • Pregnancy or breast-feeding patients
  • Known intolerance to the material, mesh-implants under investigation
  • Metastatic breast cancer (with a life expectancy < 5 years)
  • Medicinal dis-regulated diabetes
  • Inadequate bone marrow function with neutrophil granulocytes<1500 and blood plates < 100.000/µl
  • Lack or withdrawn of written patients informed consent
  • Lack of patient compliance regarding data collection, treatment or follow-up investigations in the scope of the protocol
  • Participant is institutionalized by court or official order (MPDG §27)
  • Participation in another surgical clinical investigation that influence the surgical technique or outcome.

Study details

Implant Based Breast Reconstruction

NCT06511167

AWOgyn

25 April 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.